Cargando…
Gemcitabine and Cisplatin induced posterior reversible encephalopathy syndrome: A case report with review of literature
Posterior reversible encephalopathy syndrome (PRES) is a recently described, scarcely documented clinical entity. PRES is caused by various factors, the most common being hypertension, followed by nonhypertensive causes such as renal diseases and immunosuppressive therapy. Recently, some cases have...
Autores principales: | Kabre, Rohit Santosh, Kamble, Krishna Marotirao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084490/ https://www.ncbi.nlm.nih.gov/pubmed/27843969 http://dx.doi.org/10.4103/2279-042X.192464 |
Ejemplares similares
-
A case report of posterior reversible encephalopathy syndrome in a patient receiving gemcitabine and cisplatin
por: Cherniawsky, Hannah, et al.
Publicado: (2017) -
Gemcitabine Monotherapy Associated with Posterior Reversible Encephalopathy Syndrome
por: Marrone, Luiz Carlos Porcello, et al.
Publicado: (2011) -
Posterior Reversible Encephalopathy Syndrome: A Review of the Literature
por: Ando, Yuya, et al.
Publicado: (2021) -
Posterior reversible encephalopathy syndrome at term pregnancy
por: Achar, Shreepathi Krishna, et al.
Publicado: (2011) -
A Case of Posterior Reversible Encephalopathy Syndrome Induced by Cisplatin/Pemetrexed Chemotherapy for Lung Cancer
por: Ishihara, Masashi, et al.
Publicado: (2017)